Steve Nissen: Hero Or Zero? You Decide
2 CommentsBy Ed Silverman // May 30th, 2007 // 4:24 pm
You can do so by visiting PharmaGossip, where there’s a poll equal to anything seen on CafePharma.
So far, just 48 votes are in, but there’s no clear consenus on the good doctor, who has developed a reputation in some circles as a drugslayer:
· 23 respondents, or 48 percent, say Nissen is a hero;
· 21 respondents, or 44 percent, say he’s a big fat zero,
· and 4 people can’t decide and simply say he’s an ‘other.’
Hurry, this may be your last chance to validate Chuck Grassley, who wants JP Garnier’s scalp (or what’s left of it) for the way Glaxo handled Avandia data. Conversely, you can assuage Scott Gottlieb, who says the New England Journal of Medicine committed journalistic malpractice by running Nissen’s study (although his editorial* in The Wall Street Journal omitted his ties to big pharma).
* - subscription required
Lisa Van Syckel
Thank God, Scotty doesn’t see patients.
VentureBeat » Brownian motion: Personnel moves within the life sciences
[...] This last one is a bit old, but still worth noting. Scott Gottlieb, the former FDA official turned American Enterprise Institute pundit, whose various opinings on the biotech industry we have noted here and here, is apparently also a paid consultant to Novartis — an association that for some reason never seems to get noted when he writes long attacks on the New England Journal of Medicine for the WSJ’s editorial page. Perhaps readers can benefit from this information the next time Gottlieb unburdens himself of his accumulated wisdom. (Hat tip: Pharmalot.) [...]